Translate Bio Inc TBIO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:32 AM EDT
18.53quote price arrow down-0.31 (-1.65%)
Volume
240,107
52 week range
9.64 - 34.64

...

Loading . . .
  • Open18.91
  • Day High18.91
  • Day Low18.35
  • Prev Close18.84
  • 52 Week High34.64
  • 52 Week High Date02/08/21
  • 52 Week Low9.64
  • 52 Week Low Date04/21/20

Key Stats

  • Market Cap1.394B
  • Shares Out75.21M
  • 10 Day Average Volume1.29M
  • Dividend-
  • Dividend Yield-
  • Beta0.75
  • YTD % Change1.14

KEY STATS

  • Open18.91
  • Day High18.91
  • Day Low18.35
  • Prev Close18.84
  • 52 Week High34.64
  • 52 Week High Date02/08/21
  • 52 Week Low9.64
  • 52 Week Low Date04/21/20
  • Market Cap1.394B
  • Shares Out75.21M
  • 10 Day Average Volume1.29M
  • Dividend-
  • Dividend Yield-
  • Beta0.75
  • YTD % Change1.14

RATIOS/PROFITABILITY

  • EPS (TTM)-0.87
  • P/E (TTM)-21.31
  • Fwd P/E (NTM)-79.19
  • EBITDA (MRQ)-45.915M
  • ROE (MRQ)-21.08%
  • Revenue (MRQ)138.81M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-38.75%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Translate Bio Inc

There is no recent news for this security.

Profile

MORE
Translate Bio, Inc. is a messenger RNA, or mRNA, therapeutics company. The Company is developing medicines to treat diseases caused by protein or gene dysfunction. The Company is using its proprietary mRNA therapeutic platform, or MRT platform, and it create mRNA that encodes functional proteins. The mRNA is delivered to the target cell where the cell’s own machinery recognizes it and translates it, restoring or augmenting protein function to treat or prevent disease. The MRT...
Daniel Lynch
Chairman
Ronald Renaud Jr.
Chief Executive Officer
Everett Sutherland
President
Paul Burgess J.D.
Chief Operating Officer
Frank DeRosa Ph.D.
Chief Technology Officer
Robert Prentiss
Chief Accounting Officer
Address
29 Hartwell Ave
Lexington, MA
02421-3102
United States

Top Peers

SYMBOLLASTCHG%CHG
CARA
Cara Therapeutics Inc
28.11-0.40-1.40%
IMGN
ImmunoGen Inc
7.24-0.28-3.79%
RGNX
Regenxbio Inc
33.15-1.36-3.94%
PGEN
Precigen Inc
7.34-0.15-2.00%
SGMO
Sangamo Therapeutics Inc
11.19-0.29-2.53%